WilmerHale Advises Verde Bioresins, Inc. in Business Combination with TLGY Acquisition Corporation

WilmerHale Advises Verde Bioresins, Inc. in Business Combination with TLGY Acquisition Corporation

Client News

Related Solutions

Leveraging regulatory and corporate experience to solve legal challenges for defense tech companies.
WilmerHale lawyers have decades of experience advising public and private companies in all aspects of mergers and acquisitions.

On June 22, 2023, Verde Bioresins, Inc., a full-service Los Angeles-based bioplastics product company, announced it had entered into a business combination agreement with TLGY Acquisition Corporation (Nasdaq: TLGY), a special purpose acquisition company, in a transaction implying a $365 million pre-money enterprise value to Verde. Upon closing of the business combination, the combined company is expected to list its common stock on Nasdaq under the new ticker symbol "VRDE."

Verde produces PolyEarthylene – a proprietary renewable resin created mainly from plant-based raw materials – which can be used for injection molding, blow molding, film extrusion, thermoforming and rigid packaging.

TLGY is a blank check company incorporated for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses.

The WilmerHale legal team advising Verde includes Daniel Zimmermann, Michael Gilligan, Glenn Pollner, Julie Hogan Rodgers, Ciara Baker, Scott Kilgore, Dimitry Lensky, Yvonne Elosiebo, Meghan Walsh, Victoria Peluso and Giancarlos Rodriguez.

Notice

We appreciate your interest in WilmerHale. While we are pleased to have you contact us, please keep in mind that merely contacting WilmerHale does not create an attorney-client relationship. Such a relationship will not arise until the Firm agrees in writing to represent you in connection with a particular matter. Importantly, unless and until this has occurred, you should not provide us with any confidential information, and we have no duty to keep confidential any information that we may receive from you. Thank you for your understanding.

I Accept Cancel